These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15752936

  • 41. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 42. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 43. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A.
    Acta Anaesthesiol Scand; 2006 Mar 12; 50(3):340-7. PubMed ID: 16480468
    [Abstract] [Full Text] [Related]

  • 44. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 45. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM, Gristina T, Brusca I, Serio G, Taormina A, La Chiusa SM, Castello A, Borruso E, Paterna S, Di Pasquale P.
    Minerva Cardioangiol; 2007 Apr 17; 55(2):149-55. PubMed ID: 17342035
    [Abstract] [Full Text] [Related]

  • 46. A Retrospective Study of Hemodynamic Changes in Patients After Off-Pump Coronary Artery Bypass Graft Surgery Using Impedance Cardiography.
    Niu X, Zhang Q, Xiao D, Zhang Y.
    Med Sci Monit; 2019 May 10; 25():3454-3462. PubMed ID: 31073116
    [Abstract] [Full Text] [Related]

  • 47. The Value of Echocardiography Combined with NT-pro BNP Level in Assessment and Prognosis of Diastolic Heart Failure.
    Chen S, Zhou Y, Wu X, Shi S, Wu H, Li P.
    Comput Math Methods Med; 2022 May 10; 2022():2102496. PubMed ID: 35169397
    [Abstract] [Full Text] [Related]

  • 48. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T, Gegenhuber A, Poelz W, Haltmayer M.
    Heart; 2005 May 10; 91(5):606-12. PubMed ID: 15831643
    [Abstract] [Full Text] [Related]

  • 49. [The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients].
    Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA.
    Dtsch Med Wochenschr; 2002 Dec 06; 127(49):2605-9. PubMed ID: 12469271
    [Abstract] [Full Text] [Related]

  • 50. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J, Linnaluoto M, Peuhkurinen K, Anglo-Scandinavian Cardiac Outcomes Trial Investigators.
    Int J Cardiol; 2004 Nov 06; 97(2):251-6. PubMed ID: 15458692
    [Abstract] [Full Text] [Related]

  • 51. Complex assessment of patients with decompensated heart failure: The clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide.
    Galas A, Krzesiński P, Gielerak G, Piechota W, Uziębło-Życzkowska B, Stańczyk A, Piotrowicz K, Banak M.
    Heart Lung; 2019 Nov 06; 48(4):294-301. PubMed ID: 30391076
    [Abstract] [Full Text] [Related]

  • 52. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings.
    Mak GS, DeMaria A, Clopton P, Maisel AS.
    Am Heart J; 2004 Nov 06; 148(5):895-902. PubMed ID: 15523324
    [Abstract] [Full Text] [Related]

  • 53. The detection of left ventricular diastolic dysfunction in hypertensive patients: Performance of N-terminal probrain natriuretic peptide.
    Barutçuoglu B, Parildar Z, Başol G, Gürgün C, Tekin Y, Bayindir O.
    Blood Press; 2010 Aug 06; 19(4):212-7. PubMed ID: 20070249
    [Abstract] [Full Text] [Related]

  • 54. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients.
    Jefic D, Lee JW, Jefic D, Savoy-Moore RT, Rosman HS.
    Chest; 2005 Jul 06; 128(1):288-95. PubMed ID: 16002948
    [Abstract] [Full Text] [Related]

  • 55. A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction.
    Atisha D, Bhalla MA, Morrison LK, Felicio L, Clopton P, Gardetto N, Kazanegra R, Chiu A, Maisel AS.
    Am Heart J; 2004 Sep 06; 148(3):518-23. PubMed ID: 15389242
    [Abstract] [Full Text] [Related]

  • 56. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
    Nakamura M, Tanaka F, Sato K, Segawa T, Nagano M.
    J Card Fail; 2005 Dec 06; 11(9):705-12. PubMed ID: 16360967
    [Abstract] [Full Text] [Related]

  • 57. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.
    McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ.
    Heart; 2001 Jul 06; 86(1):21-6. PubMed ID: 11410555
    [Abstract] [Full Text] [Related]

  • 58. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women.
    Hedberg P, Lönnberg I, Jonason T, Nilsson G, Pehrsson K, Ringqvist I.
    Am Heart J; 2004 Sep 06; 148(3):524-9. PubMed ID: 15389243
    [Abstract] [Full Text] [Related]

  • 59. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 60. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
    Giallauria F, De Lorenzo A, Pilerci F, Manakos A, Lucci R, Psaroudaki M, D'Agostino M, Del Forno D, Vigorito C.
    Eur J Cardiovasc Prev Rehabil; 2006 Aug 20; 13(4):625-32. PubMed ID: 16874155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.